Trapezius Port Placement in Patients with Breast Cancer: Long-Term Follow-up and Quality-of-Life Assessment.


Journal

Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369

Informations de publication

Date de publication:
01 2019
Historique:
received: 08 05 2018
revised: 14 08 2018
accepted: 14 08 2018
pubmed: 12 12 2018
medline: 7 5 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

To evaluate the long-term results of and patient satisfaction with trapezius ports in breast cancer patients, as an alternative to chest ports. This retrospective study included all patients who underwent trapezius port placement from December 2007 to January 2017. Seventy female patients with breast cancer, with a mean age of 54 ± 9.9 years (range, 29-76 years), were included. Indications for trapezius implantation were bilateral breast surgery or unilateral breast surgery and contralateral breast involvement. Sixty-eight of 70 patients had long-term follow-up. A retrospective, questionnaire-based survey was conducted to assess satisfaction and the trapezius port's effect on the daily life of the patient. All implantations were technically successful. Total catheter service time for 68 patients was 65,952 days (2 patients were lost to follow-up). Mean catheter service time was 969.8 days (range 7-3,458 days; median 570 days; 95% confidence interval, 739-1199; standard deviation, 947.7). No immediate procedural complications occurred. Port complications developed in 4 patients (5.9%); port infection developed in 2 patients (0.03/1,000 days); skin dehiscence developed in 1 patient (0.02/1,000 days); and port malfunction developed in 1 patient (0.02/1,000 days). The overall infection rate was 2.9% (2/68). All patients (n = 44) or a close relative (n = 17) who were interviewed with a phone call reported satisfaction regarding their ports. Trapezius ports offer a safe and feasible option to patients with breast cancer who need an alternative site to chest ports. It is also associated with high overall patient satisfaction.

Identifiants

pubmed: 30527656
pii: S1051-0443(18)31418-0
doi: 10.1016/j.jvir.2018.08.011
pii:
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-73

Informations de copyright

Copyright © 2018 SIR. Published by Elsevier Inc. All rights reserved.

Auteurs

Barbaros Erhan Çil (BE)

Department of Radiology, Faculty of Medicine, Hacettepe University, Ankara 34010, Turkey; Department of Radiology, Koç University Hospital, Istanbul, Turkey. Electronic address: bcil@kuh.ku.edu.tr.

Osman Öcal (O)

Department of Radiology, Faculty of Medicine, Hacettepe University, Ankara 34010, Turkey.

Fatma Gonca Eldem (FG)

Department of Radiology, Faculty of Medicine, Hacettepe University, Ankara 34010, Turkey.

Bora Peynircioğlu (B)

Department of Radiology, Faculty of Medicine, Hacettepe University, Ankara 34010, Turkey.

Ferhun Balkancı (F)

Department of Radiology, Faculty of Medicine, Hacettepe University, Ankara 34010, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH